| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |